Back to Journals » Clinical Ophthalmology » Volume 4

Use of nepafenac (Nevanac®) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections

Total article views   Abstract views HTML views PDF downloads Totals
9,621 Dovepress* 7,687 464+ 1,757 8,151
PubMed Central* 11 1,459 321 1,470
Totals 7,698 1,923 2,078 9,621
*Since 28 October 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar